Summary of equity attributable to Novartis AG shareholders (Tables)

6 Months Ended

Jun. 30, 2026

Disclosure of equity [abstract]

Schedule disclosing information related treasury shares movements

				Number of outstanding shares (in millions)				Equity attributable to Novartis AG shareholders



		Note		2026		2025		H1 2026 USD millions		H1 2025 USD millions

Balance at beginning of year				1 908.2		1 975.1		46 130		44 046

Shares acquired to be canceled				-18.2		-48.8		-2 771		-5 350

Other share purchases				-2.0		-1.6		-292		-159

Equity-based compensation plans				12.6		11.1		616		557

Taxes on treasury share transactions								-23		-33

Dividends		4.1						-9 068		-7 818

Net income of the period attributable to shareholders of Novartis AG								6 420		7 647

Other comprehensive income attributable to shareholders of Novartis AG								432		3 027

Changes in non-controlling interests										1

Other movements		4.3		0.1		0.1		98		67

Balance at June 30				1 900.7		1 935.9		41 542		41 985